Lu Chen

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

MiR-183-5p promotes renal cell carcinoma metastasis by targeting TET1.

MiR-183-5p promotes renal cell carcinoma metastasis by targeting TET1.

Journal: International journal of immunopathology and pharmacology
Published: August 16, 2023

Stimulation by Exosomes from Hypoxia Preconditioned Human Umbilical Vein Endothelial Cells Facilitates Mesenchymal Stem Cells Angiogenic Function for Spinal Cord Repair.

Stimulation by Exosomes from Hypoxia Preconditioned Human Umbilical Vein Endothelial Cells Facilitates Mesenchymal Stem Cells Angiogenic Function for Spinal Cord Repair.

Journal: ACS nano
Published: July 05, 2022

Blockade LAT1 Mediates Methionine Metabolism to Overcome Oxaliplatin Resistance under Hypoxia in Renal Cell Carcinoma.

Blockade LAT1 Mediates Methionine Metabolism to Overcome Oxaliplatin Resistance under Hypoxia in Renal Cell Carcinoma.

Journal: Cancers
Published: April 17, 2022

miR-373-3p Regulates the Proliferative and Migratory Properties of Human HTR8 Cells via SLC38A1 Modulation.

miR-373-3p Regulates the Proliferative and Migratory Properties of Human HTR8 Cells via SLC38A1 Modulation.

Journal: Disease markers
Published: March 31, 2022

miR-224-5p Contained in Urinary Extracellular Vesicles Regulates PD-L1 Expression by Inhibiting Cyclin D1 in Renal Cell Carcinoma Cells.

miR-224-5p Contained in Urinary Extracellular Vesicles Regulates PD-L1 Expression by Inhibiting Cyclin D1 in Renal Cell Carcinoma Cells.

Journal: Cancers
Published: December 09, 2020

The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents.

The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents.

Journal: Frontiers in pharmacology
Published: September 10, 2019

The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma.

The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma.

Journal: Theranostics
Published: September 03, 2019

Regulation of OCT2 transcriptional repression by histone acetylation in renal cell carcinoma.

Regulation of OCT2 transcriptional repression by histone acetylation in renal cell carcinoma.

Journal: Epigenetics
Published: May 16, 2019

A novel human lncRNA SANT1 cis-regulates the expression of SLC47A2 by altering SFPQ/E2F1/HDAC1 binding to the promoter region in renal cell carcinoma.

A novel human lncRNA SANT1 cis-regulates the expression of SLC47A2 by altering SFPQ/E2F1/HDAC1 binding to the promoter region in renal cell carcinoma.

Journal: RNA biology
Published: April 06, 2019

Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2.

Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2.

Journal: Acta pharmaceutica Sinica. B
Published: August 25, 2018
Showing 1-10 of 10

Last Updated: 09/26/2026